Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05459948

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

Medacta GMK® SpheriKA and Kinematic Alignment Technique Multicenter, Post-Market Outcome Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
281 (estimated)
Sponsor
Medacta International SA · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

This is a Post-Marketing Surveillance of GMK SpheriKA knee stem prosthesis.

Detailed description

The aim of the current study is to collect clinical and radiological data to monitor the performances of the "GMK® SpheriKA" Knee Prosthesis implanted via the kinematic alignment technique.

Conditions

Interventions

TypeNameDescription
DEVICEGMK SpheriKAThe first objective is to study the FJS of patients who were implanted a "GMK® SpheriKA" knee prosthesis using the kinematic alignment technique

Timeline

Start date
2022-07-30
Primary completion
2035-05-01
Completion
2035-05-01
First posted
2022-07-15
Last updated
2025-09-29

Locations

4 sites across 3 countries: France, Italy, Switzerland

Source: ClinicalTrials.gov record NCT05459948. Inclusion in this directory is not an endorsement.

The Medacta GMK SpheriKA Post-Marketing Surveillance Study (NCT05459948) · Clinical Trials Directory